AKERO THERAPEUTICS INC (AKRO)

US00973Y1082 - Common Stock

25.26  +0.81 (+3.31%)

After market: 25.26 0 (0%)

Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to AKRO. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 52.02. This target is 105.94% above the current price.
AKRO was analyzed by 15 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about AKRO.
In the previous month the buy percentage consensus was at a similar level.
AKRO was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 25.2642.4251.0052.0263.00 - 67.93% 101.90% 105.94% 149.41%
Up and Down Grades
Date Firm Action Rating
2024-03-05 UBS Maintains Buy -> Buy
2024-03-05 HC Wainwright & Co. Maintains Buy -> Buy
2024-03-01 HC Wainwright & Co. Maintains Buy -> Buy
2023-11-14 HC Wainwright & Co. Reiterate Buy -> Buy
2023-10-12 UBS Maintains Buy -> Buy
2023-10-11 Cantor Fitzgerald Maintains Overweight -> Overweight
2023-10-11 JP Morgan Maintains Overweight -> Overweight
2023-10-11 Morgan Stanley Maintains Overweight -> Overweight
2023-10-11 HC Wainwright & Co. Maintains Buy -> Buy
2023-10-04 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-09-19 Cantor Fitzgerald Initiate Overweight
2023-09-13 Evercore ISI Group Maintains Outperform -> Outperform
2023-09-05 JP Morgan Maintains Overweight -> Overweight
2023-08-28 UBS Initiate Buy
2023-06-12 Morgan Stanley Maintains Overweight
2023-06-07 HC Wainwright & Co. Maintains Buy -> Buy
2023-05-17 Canaccord Genuity Maintains Buy -> Buy
2023-05-16 HC Wainwright & Co. Maintains Buy -> Buy
2023-03-21 Canaccord Genuity Maintains Buy
2023-03-20 HC Wainwright & Co. Reiterate Buy
2023-01-27 Morgan Stanley Upgrade Equal-Weight -> Overweight
2022-11-07 Morgan Stanley Maintains Equal-Weight
2022-11-07 HC Wainwright & Co. Maintains Buy
2022-09-14 Evercore ISI Group Upgrade In-Line -> Outperform
2022-09-14 Morgan Stanley Maintains Equal-Weight
2021-11-15 Morgan Stanley Maintains Equal-Weight
2021-11-15 HC Wainwright & Co. Maintains Buy
2021-10-19 Morgan Stanley Downgrade Overweight -> Equal-Weight
2021-09-10 B of A Securities Initiate Buy
2021-08-16 HC Wainwright & Co. Maintains Buy